z-logo
Premium
The discriminative stimulus effects of nitrous oxide in B6SJLF1/J mice
Author(s) -
Richardson Kellianne J,
Shelton Keith L
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.658.9
Subject(s) - nmda receptor , chemistry , dizocilpine , pharmacology , nitrous oxide , isoflurane , antagonism , antagonist , stimulus control , receptor , anesthesia , medicine , biochemistry , nicotine , organic chemistry
The abuse‐related CNS effects of nitrous oxide (N 2 O) are poorly understood. In vitro data suggests that N 2 O alters the function of NMDA and GABA A receptors, amongst others. Our goal was to assess the neurotransmitter systems responsible for producing the intoxicating effects of N 2 O using drug discrimination. Twenty‐four mice were trained to discriminate 10 min of exposure to 60% N 2 O/40% O 2 versus 100% O 2 in daily 5 min operant sessions. Mice acquired the discrimination in an average of 38 days. N 2 O produced concentration‐dependent substitution for the training concentration. Full substitution required 7 min of 60% N 2 O exposure but the offset of stimulus effects N 2 O following the cessation of exposure was more rapid. In substitution studies the NMDA channel blocker MK‐801 produced up to 49% N 2 O lever‐selection at 0.56 mg/kg. While MK‐801 failed to produce more than partial substitution, an intermediate dose of 0.17 mg/kg MK‐801 significantly shifted the N 2 O concentration‐effect curve to the left. The competitive NMDA antagonist CGS 19755 and the positive GABA A modulator midazolam failed to substitute for N 2 O. Volatile anesthetic vapors methoxyflurane and isoflurane partially substituted for N 2 O. These data suggest the subjective stimulus properties of N 2 O may be partially mediated by NMDA antagonism but other receptor systems not yet examined are probably also involved. Supported by NIDA grant RO1‐DA020553.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here